The delinquent quarterly filings and failure to file Form 12b-25 are red flags for SEC compliance. Monitor for any SEC enforcement action, trading suspension, or going-concern language in the overdue Q1/Q2 2026 reports. The stock is at elevated risk of being delisted or halted until filings are current.
Price Chart
Executive Summary
Regenerex Pharma filed an 8-K disclosing that its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 are delinquent. The company recently filed its late 2025 10-K and did not file required late-filing notices (Form 12b-25) for the missing quarterly reports. This signals ongoing material weaknesses in financial reporting and SEC compliance for an OTC-traded micro-cap pharmaceutical company, increasing the risk of trading suspension or SEC enforcement action until filings are current.
Key Facts
- Quarterly Reports on Form 10-Q for Q1 2026 (March 31) and Q2 2026 (June 30) are delinquent and have not been filed with the SEC.
- The company did not file Notifications of Late Filing on Form 12b-25 for either of the outstanding quarterly reports.
- The 2025 Form 10-K was filed after the applicable filing deadline.
- The company acknowledges the delay is due to substantial additional accounting, reconciliation, and financial reporting work required.
- Management states it is actively working to complete the reports but provides no specific timeline for filing.
Financial Impact
No financial figures provided in the filing. The company is delinquent on two quarterly reports with no revenue or expense data disclosed.
Risk Factors
- SEC enforcement action or trading suspension for delinquent filings
- Potential going-concern or material weakness disclosures in the overdue quarterly reports
- Inability to raise capital or execute business strategy without current SEC filings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001472375-26-000214 |
| Document: 0001472375-26-000214-index-headers.html | 0001472375-26-000214 |
| Document: 0001472375-26-000214-index.html | 0001472375-26-000214 |
| Document: 0001472375-26-000214.txt | 0001472375-26-000214 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 7w ago | 8-K | — | awaiting T+20 | — | — |
Sep 1, 2026 7w ago | 8-K | — | awaiting T+20 | — | — |
Jun 11, 2026 19w ago | 8-K | — | awaiting T+20 | — | — |
May 6, 2026 24w ago | 8-K | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers